Arctic Bioscience Logo

Arctic Bioscience

Develops pharmaceutical and nutraceutical products from marine membrane lipids.

ABS | OL

Overview

Corporate Details

ISIN(s):
NO0010859580
LEI:
549300Z2HW6I989Q2C78
Country:
Norway
Address:
Industrivegen 42, 6155 ØRSTA

Description

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-18 09:33
Financial calendar
English 498 bytes
2025-12-18 09:33
Finansiell kalender
Norwegian 485 bytes
2025-12-17 11:38
Arctic Bioscience - Share capital increase registered
English 1.8 KB
2025-12-17 11:38
Arctic Bioscience - Registrert aksjekapitalforhøyelse
Norwegian 1.7 KB
2025-12-12 16:05
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldsko…
Norwegian 476.7 KB
2025-12-12 16:05
Arctic Bioscience - Board approval of share capital increase related to convers…
Norwegian 476.7 KB
2025-12-12 16:05
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldsko…
Norwegian 363.8 KB
2025-12-12 16:05
Arctic Bioscience - Board approval of share capital increase related to convers…
Norwegian 363.8 KB
2025-12-12 16:05
Arctic Bioscience - Styrets godkjennelse av kapitaløkning relatert til gjeldsko…
Norwegian 2.3 KB
2025-12-12 16:05
Arctic Bioscience - Board approval of share capital increase related to convers…
English 2.4 KB
2025-11-11 12:04
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling - Attachment:…
Norwegian 346.3 KB
2025-11-11 12:04
Arctic Bioscience - Minutes of the Extraordinary General Meeting - Attachment: …
Norwegian 346.3 KB
2025-11-11 12:04
Arctic Bioscience - Protokoll fra ekstraordinær generalforsamling
Norwegian 1.6 KB
2025-11-11 12:04
Arctic Bioscience - Minutes of the Extraordinary General Meeting
English 1.6 KB
2025-11-10 07:00
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemi…
English 4.1 MB

Automate Your Workflow. Get a real-time feed of all Arctic Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Arctic Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Arctic Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.